---
title: "Dynavox Group CFO to Step Down in Planned Transition by January 2027"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/279902984.md"
description: "Dynavox Group AB announced that CFO Linda Tybring will step down by January 31, 2027, to ensure a smooth transition and assist in recruiting her successor. The company has begun an immediate search for a new CFO, highlighting Tybring's significant contributions to its growth, including its 2021 carve-out from Tobii and international acquisitions. The transition aims to maintain operational continuity during ongoing expansion. The current analyst rating for Dynavox Group stock is a Hold with a price target of SEK125.00."
datetime: "2026-03-20T07:36:43.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/279902984.md)
  - [en](https://longbridge.com/en/news/279902984.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/279902984.md)
---

# Dynavox Group CFO to Step Down in Planned Transition by January 2027

### Claim 70% Off TipRanks Premium

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential

Dynavox Group AB ( (SE:DYVOX) ) just unveiled an update.

Dynavox Group has announced that Chief Financial Officer Linda Tybring will step down from her role by 31 January 2027, remaining in post to support a smooth transition and the recruitment and onboarding of her successor. The company has initiated an immediate search process, with management emphasizing Tybring’s importance to its development and her commitment to maintaining momentum during the transition.

Tybring has been a key figure in Dynavox Group’s evolution, playing central roles in its 2021 carve-out from Tobii, listing on Nasdaq Stockholm, implementation of global ERP systems, and several international acquisitions that helped triple the size of the business. Her planned and lengthy handover period is designed to minimize operational disruption and reassure investors and other stakeholders about continuity in financial leadership during a phase of ongoing international expansion.

The most recent analyst rating on (SE:DYVOX) stock is a Hold with a SEK125.00 price target. To see the full list of analyst forecasts on Dynavox Group AB stock, see the SE:DYVOX Stock Forecast page.

**More about Dynavox Group AB**

Dynavox Group AB is the parent company of Tobii Dynavox, a global leader in assistive communication technologies. Headquartered in Stockholm and listed on Nasdaq Stockholm under the ticker DYVOX, the company employs over 1,000 people and serves customers in more than 65 countries.

Its custom-designed hardware, software, language systems, and mounting solutions help individuals with conditions such as cerebral palsy, ALS, autism, and spinal cord injuries communicate, build literacy, and live more independently. The offering includes AI-based speech synthesis in over 30 languages, alternative access methods like eye gaze and touch screens, and extensive support and funding expertise.

**Average Trading Volume:** 366,719

**Technical Sentiment Signal:** Buy

**Current Market Cap:** SEK8.92B

For an in-depth examination of DYVOX stock, go to TipRanks’ Overview page.

### Related Stocks

- [DVAX.US](https://longbridge.com/en/quote/DVAX.US.md)

## Related News & Research

- [BUZZ-PREVIEW-'Challenging Q4' for Indian pharma firm Dr Reddy's, analysts say](https://longbridge.com/en/news/286037312.md)
- [Candy-Coated Costs: How Unvalidated Hemp Gummies Found a Back Door Into Medicare](https://longbridge.com/en/news/285975421.md)
- [Ernexa Therapeutics Releases Virtual Investor KOL Connect Segment Highlighting Ovarian Cancer Landscape and Lead Candidate ERNA-101 | ERNA Stock News](https://longbridge.com/en/news/285952615.md)
- [Dr. Reddy’s Grants Over 1.19 Million Employee Stock Options Under ESOP and ADR Schemes](https://longbridge.com/en/news/285977383.md)
- [Pliant Therapeutics Q1 net loss narrows on lower expenses](https://longbridge.com/en/news/285998196.md)